Variant

As the authors write, the advancement conjures a "complex ethical conundrum" because the genomic information captured "comes from individuals mostly unaware of the technology use and oblivious to the fact that their genetic information has been inadvertently obtained."

Research shows that "the duration of protection after breakthrough infection was longer than after the third/booster vaccination."

Children diagnosed with the Omnicron subvariant XBB.1.16 report conjunctivitis symptoms.

"[T]he fact that the studies that do exist (including our own late addition) fail to show convincing evidence of benefit from masking suggests that, if there is a benefit, it is a rather modest one, i.e. masks may reduce the risk slightly but do not guarantee you won’t get infected," said Dr. Breathnach.

Switzerland has stopped recommending COVID-19 vaccination for spring/summer 2023 due to high vaccination rates and natural immunity from prior infection.

The World Health Organization acknowledged there are "comparatively low public health returns" for some groups receiving the COVID-19 booster.

"People aren't really opposed, but they do need a push, a push and a drag," joked DC Mayor Muriel Bowser.

The meta-analysis claims, "The level of protection against re-infection, symptomatic disease, and severe disease appears to be at least as durable, if not more so, than that provided by two-dose vaccination with the mRNA vaccines."

A new preprint by Wilson N. Sy, PhD, Director of the Biotechnology Unit at Investment Analytics Research located in Australia, finds that excess deaths in Australia in 2021 were likely due to vaccination, not COVID-19 mortality.

“To be clear, we do not, and never would, engage in research to create or adapt viruses with the intention of making them more contagious or harmful to people," Pfizer said to Rep. Ronny Jackson (R-TX).